Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IPOD vs ABTS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IPOD Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 9–0 Matrix Metrics)

IPOD Overall Winner 6-Pillar Tally: IPOD 2 – 2 ABTS (2 Tie) Matrix Metrics: IPOD 9 – 0 ABTS

As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABTS carries 48.4/100 (HOLD) at $0.33 (N/M Forward P/E, -46.3% operating margin).

  • Technical & Structure Timing Caution: IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ABTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IPOD vs ABTS
IPOD US Equity Head-to-Head Winner
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 2% Vol
Unified Composite Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
ABTS NASDAQ
Abits Group Inc Ordinary Shares
Finance Services
$0.33
-1.72% 1D
Market Cap $1.2M
TTM Revenue $8.3M
Forward P/E N/M
Beta / 30D Vol 1.73β · 224% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.8%), weak momentum, RSI 17
RSI-14: 16.8 · SMA20: $0.77 · SMA50: $1.07

6-Pillar Scorecard Institutional Category Breakdown (IPOD 2 – 2 ABTS)

Columns: Metric · IPOD · ABTS
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E 39.9x N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.4x
2. Growth & Scale IPOD
Revenue Growth (YoY) +0.0% -20.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $8.3M
Market Cap $210.0M $1.2M
3. Profitability & Quality IPOD
Gross Margin N/A 23.7%
Operating Margin 0.0% -46.3%
Net Profit Margin 0.0% -60.8%
Return on Equity (ROE) 0.0% -60.0%
4. Balance Sheet & Cash Flow ABTS
Cash Generation (TTM) N/A $73,322 EBITDA
Cash Flow Margin N/A 0.9% EBITDA Mgn
Net Cash / Leverage 0.0% ROE $1.8M Net Debt (0.24x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ABTS
OpEx & R&D Intensity N/A 70.0% of Rev ($5.8M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IPOD (9) vs ABTS (0)
Institutional Metric IPOD ABTS Criterion Row Edge
Market Capitalization
Scale
$210.0M $1.2M Larger Scale IPOD
Trailing P/E Ratio
Valuation
39.9x N/M Lower Multiple IPOD
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% -20.0% Higher Growth IPOD
Operating Margin (TTM)
Profitability
0.0% -46.3% Higher Margin IPOD
Net Profit Margin
Profitability
0.0% -60.8% Higher Margin IPOD
Return on Equity (ROE)
Capital Efficiency
0.0% -60.0% Higher ROE IPOD
52-Week Range Position
Momentum
100% ($10–$10) 0% ($0–$7) Stronger Trend IPOD
Beta / 30D Volatility
Risk Regime
0.00β · 2% Vol 1.73β · 224% Vol Lower Realized Risk IPOD
Unified Institutional Score
Composite Signal
58.0 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite IPOD
Trailing 12M Revenue (USD)
Operating Scale
N/A $8.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 23.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) $73,322 EBITDA ($1.8M Net Debt (0.24x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IPOD +47.64 pp
IPOD: +0.97% · ABTS: -46.67%
3M Horizon IPOD +87.42 pp
IPOD: +2.46% · ABTS: -84.96%
6M Horizon IPOD +88.02 pp
IPOD: +1.76% · ABTS: -86.26%
1Y Horizon IPOD +88.02 pp
IPOD: +1.76% · ABTS: -86.26%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABTS. Trailing 12-month operating profitability (IPOD 0.0% vs ABTS -46.3%) and valuation multiples (IPOD N/M vs ABTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IPOD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
ABTS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$8.3M
Gross Margin23.7%
Op. Margin-46.3%
ROE / Fwd P/E-60.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IPOD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPOD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABTS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IPOD Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABTS Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $1.2M market capitalization and -46.3% operating margin.
OpEx & R&D Reinvestment 70.0% of Rev ($5.8M)
90D Engineering Disclosures 0 Published

Investor FAQ IPOD vs ABTS Key Questions & Quantitative Answers

As of Nov 16, 2026, IPOD (IPOD) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABTS carries 48.4/100 (HOLD) at $0.33 (N/M Forward P/E, -46.3% operating margin). Technical & Structure Timing Caution: IPOD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ABTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IPOD leads the Growth & Scale pillar: IPOD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABTS at -20.0% YoY revenue growth and +0.0% YoY earnings growth on $8.3M TTM revenue (23.7% gross margin, -46.3% operating margin). On trailing 12-month operating scale, IPOD generates N/A in USD-normalized revenue versus $8.3M for ABTS. In operating R&D and SG&A reinvestment, IPOD deploys N/A (0 90-day corporate R&D disclosures) versus 70.0% of Rev ($5.8M) (0 disclosures) for ABTS.

IPOD and ABTS trade at balanced relative valuation multiples. IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (0.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPOD (0.0% ROE) versus ABTS (-60.0% ROE) capital efficiency.

In options market volatility and institutional positioning, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, ABTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.73β · 224% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.